1. Home
  2. AWRE vs VNRX Comparison

AWRE vs VNRX Comparison

Compare AWRE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.93

Market Cap

44.5M

Sector

Technology

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.27

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
VNRX
Founded
1986
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.5M
38.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AWRE
VNRX
Price
$1.93
$0.27
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
37.5K
2.2M
Earning Date
10-29-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
$1,472,007.00
Revenue This Year
N/A
$55.98
Revenue Next Year
N/A
$420.37
P/E Ratio
N/A
N/A
Revenue Growth
2.72
14.48
52 Week Low
$1.37
$0.22
52 Week High
$2.95
$0.94

Technical Indicators

Market Signals
Indicator
AWRE
VNRX
Relative Strength Index (RSI) 37.27 45.05
Support Level $1.80 $0.22
Resistance Level $2.09 $0.26
Average True Range (ATR) 0.10 0.02
MACD -0.01 0.01
Stochastic Oscillator 30.95 60.42

Price Performance

Historical Comparison
AWRE
VNRX

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: